Alberta Health Services
π¨π¦Canada
- Country
- π¨π¦Canada
- Ownership
- Private
- Established
- 2009-04-01
- Employees
- 10K
- Market Cap
- -
Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-01-20
- Last Posted Date
- 2012-01-19
- Lead Sponsor
- Alberta Health services
- Target Recruit Count
- 40
- Registration Number
- NCT00279721
Presbyopia in Breast Cancer Survivors
Withdrawn
- Conditions
- First Posted Date
- 2006-01-04
- Last Posted Date
- 2011-12-09
- Lead Sponsor
- Alberta Health services
- Registration Number
- NCT00271661
Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2012-01-19
- Lead Sponsor
- Alberta Health services
- Target Recruit Count
- 70
- Registration Number
- NCT00168155
- Locations
- π¨π¦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2011-04-18
- Lead Sponsor
- Alberta Health services
- Target Recruit Count
- 220
- Registration Number
- NCT00168181
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2010-02-09
- Lead Sponsor
- Alberta Health services
- Target Recruit Count
- 60
- Registration Number
- NCT00168168
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases
Phase 1
Completed
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2011-12-09
- Lead Sponsor
- Alberta Health services
- Target Recruit Count
- 10
- Registration Number
- NCT00168129
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study
Not Applicable
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2012-01-19
- Lead Sponsor
- Alberta Health services
- Target Recruit Count
- 200
- Registration Number
- NCT00156858
- Locations
- π¨π¦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2012-01-19
- Lead Sponsor
- Alberta Health services
- Target Recruit Count
- 58
- Registration Number
- NCT00156884
- Locations
- π¨π¦
BC Cancer Agency, Vancouver, British Columbia, Canada
π¨π¦Tom Baker Cancer Centre, Calgary, Alberta, Canada
Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant (HSCT)
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2012-01-19
- Lead Sponsor
- Alberta Health services
- Target Recruit Count
- 24
- Registration Number
- NCT00156871
- Locations
- π¨π¦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-05
- Last Posted Date
- 2011-11-21
- Lead Sponsor
- Alberta Health services
- Target Recruit Count
- 60
- Registration Number
- NCT00144092
- Locations
- π¨π¦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Β© Copyright 2024. All Rights Reserved by MedPath